Home Huihe Medical's Next-Gen C-Wave® Coronary IVL System with 150 Pulses Receives NMPA Approval

Huihe Medical's Next-Gen C-Wave® Coronary IVL System with 150 Pulses Receives NMPA Approval

May 09, 2025 08:05 CST Updated 08:05
H&H Healthcare

R&D and Producer of Interventional Medical Devices for Heart Disease

Image


Recently, Shanghai Huihe Healthcare Technology Co., Ltd. (hereinafter referred to as "HuiHe Healthcare") independently developedNumber of pulses reaches 150 timesofNew Generation C-Wave®Coronary Shockwave SystemOfficially approved for marketing by the National Medical Products Administration (NMPA).


Image


Intravascular Lithotripsy (IVL), as an innovative technology for treating vascular calcified plaques, has been widely recognized in clinical practice since its introduction in China, but the existing technology is still limited byInsufficient pulse countAndPoor catheter passabilitySuch key bottlenecks. To this end, the new generation C-Wave®Comprehensive Upgrade of Coronary Shockwave Catheters——Number of pulses increased to 150 (600 shock waves),A single catheter can complete complex lesion treatment, eliminating intraoperative pulse anxiety; meanwhile, furtherOptimize Hydrophilic Coating Process, easily navigating through narrow and tortuous lesions. It not only demonstrates enhanced handling capabilities in complex calcified lesions such as long-segment diffuse, eccentric, and sharply angulated twists, but also effectively reduces procedural costs, truly achieving"More Pulses, Better Passage, Greater Cost-Effectiveness"Clinical breakthrough.


Pulse Upgrade: A New Benchmark

Image


150 Pulses, Worry-Free Treatment


New Generation C-Wave®Coronary Shockwave CatheterNumber of pulses increased by 87.5%, Single CatheterUp to 150 pulses can be released., totaling600 Shock Waves(150 times × 4 discharge points), significantly extending the treatment window, effectively alleviating "pulse anxiety" during surgery, and further improving the efficiency of vascular calcification pre-treatment.


One-Click 4-Wave, Efficient Calcium Fragmentation


C-Wave®The coronary shockwave balloon adopts a reverse-rotating dual-electrode design, with a total of 4 discharge points, throughOne-button activation can synchronously activate all sites, instantly generating 4 shock waves., achieving more efficient calcified plaque fragmentation with the same number of pulses.


Spiral Discharge Full-Cycle Impact

Image


World's First S-shaped Spiral Electrode Arrangement


C-Wave®Coronary Shockwave Catheter AdoptedGlobally Unique S-shaped Spiral Electrode, 6 electrodes are arranged in a continuous "S"-shaped linear pattern along the axis, achieving:


In the long-axis view, the four shockwaves released simultaneously are distributed across four different planes, ensuring balanced energy coverage along the entire axis, significantly enhancing...Continuous Calcification, Diffuse CalcificationIsometric Lesion Shockwave Effect.


In the short-axis plane, the energy covers 360° in all directions, while the minimum angle between adjacent shockwaves is 60°, further superimposing the energy for effective response.Eccentric calcification, Nodular calcificationFor complex lesions, no precise alignment is required, ready to use upon arrival.


Complex Lesions, Unobstructed Throughout

Image


Double-end Coating, Smooth Bending


Tip and outer catheter front-rear progressive endAll adoptHydrophilic Coating Design, ensuring smooth passage through narrow and tortuous lesions, reducing the risk of catheter entrapment, and avoiding vascular dissection and perforation caused by repeated operations during the procedure.


Ultra-thin outer diameter, smooth and unobstructed


1.08mm Ultra-thin Outer CatheterAnd0.6mm Ultra-Fine Tip Outer Diameter, further combined with precision balloon curling technology (Maximum Curl Diameter 1.20mm(Balloon diameter > 3.0mm),As small as 1.15mm(Balloon diameter ≤3.0mm), significantly enhances the passability through complex tortuous lesions and reduces the need for pre-dilation operations.

About HuiHe Healthcare


Image


HuiHe Healthcare has deeply engaged in the field of vascular intervention, building a diversified product matrix covering structural heart disease, peripheral vascular, and tumor intervention, with "original innovation" as its foundation.


Technical Confidence:Globally applied for more than 260 patents, including C-Wave®A total of 73 items in the series (47 authorized, including 11 invention patents).


R&D Hard Power:A 120+ R&D team and an 8,000㎡ R&D and production base ensure the rapid implementation of technology.


Product Ecosystem:Except C-Wave®In addition, K-Clip®Tricuspid Annuloplasty System, Vispearl®Firefly Beads®Innovative products such as visible drug-loaded microspheres work together to fully empower precision medicine.


Image

Scan the code to enter HuiHe Healthcare's academic column

Learn More Exciting Content


· END ·


Image

Copyright and Disclaimer:Yanda Medical Media Network aims to build a platform for academic dissemination and media communication. The copyright of the information in the article belongs to the holder, and we only provide information delivery services. If there is any infringement, please contact us to delete.

Click"Read the original text"EnterHuiHe Healthcare Academic Column